CoChat

Long-term study of indolent adult T-cell leukemia-lymphoma

The DOI matches its Crossref record; 31 of the 32 references it cites were found in a registry or an index.

Abstract

The long-term prognosis of indolent adult T-cell leukemia-lymphoma (ATL) is not clearly elucidated. From 1974 to 2003, newly diagnosed indolent ATL in 90 patients (65 chronic type and 25 smoldering type) was analyzed. The median survival time was 4.1 years; 12 patients remained alive for more than 10 years, 44 progressed to acute ATL, and 63 patients died. The estimated 5-, 10-, and 15-year survival rates were 47.2%, 25.4%, and 14.1%, respectively, with no plateau in the survival curve. Although most patients were treated with watchful waiting, 12 patients were treated with chemotherapy. Kaplan-Meier analyses showed that advanced performance status (PS), neutrophilia, high concentration of lactate dehydrogenase, more than 3 extranodal lesions, more than 4 total involved lesions, and receiving chemotherapy were unfavorable prognostic factors for survival. Multivariate Cox analysis showed that advanced PS was a borderline significant independent factor in poor survival (hazard ratio, 2.1, 95% confidence interval, 1.0-4.6; P = .06), but it was not a factor when analysis was limited to patients who had not received chemotherapy. The prognosis of indolent ATL in this study was poorer than expected. These findings suggest that even patients with indolent ATL should be carefully observed in clinical practice. Further studies are required to develop treatments for indolent ATL.

Overview

Integrity signals

Registry

Crossref · 10.1182/blood-2009-09-242347

Cites

31 of 31 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

1 retracted

Show all 31 references

Research works printed but not linked: 3

  1. Dale, 2006, Neutropenia and neutrophilia., 907
  2. Wardlaw, 2006, Eosinophils and their disorders., 863
  3. Tobinai, 2004, Adult T-cell leukemia-lymphoma., 3109

Cited by

See all 202

Metadata

Authors
Takasaki, Y., Iwanaga, M., Imaizumi, Y., Tawara, M., Joh, T., Kohno, T., Yamada, Y., Kamihira, S., Ikeda, S., Miyazaki, Y., Tomonaga, M., & Tsukasaki, K.
Affiliations
  • Nagasaki University (JP)
  • Division of Cytokine Signaling, Department of Molecular Microbiology and Immunology and
  • Department of Hematology, Hirado Municipal Hospital, Nagasaki, Japan
  • Japanese Red Cross Nagasaki Genbaku Hospital (JP)
Venue
Blood
Published
2010-06-03
Volume
115
Issue
22
Pages
4337-4343
ISSN
  • 0006-4971 (ISSN-L)
  • 1528-0020
OpenAlex
W2006933182
Cited by
180
References
32
Citations by year
2026: 4 · 2025: 8 · 2024: 7 · 2023: 11 · 2022: 9 · 2021: 12 · 2020: 15 · 2019: 9 · 2018: 9 · 2017: 22 · 2016: 8 · 2015: 18 · 2014: 12 · 2013: 12 · 2012: 11
FWCI
4.94
Type
journal article
Language
en
Open access
closed
Locations
  • Blood (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Immunology and Microbiology › Immunology › T-cell and Retrovirus Studies
  • Health Sciences › Medicine › Oncology › Viral-associated cancers and disorders
  • Health Sciences › Medicine › Dermatology › Cutaneous lymphoproliferative disorders research
Keywords
prognosis, survival, prognostic factors, performance status, neutrophilia, lactate dehydrogenase, extranodal lesions, chemotherapy, expectant management, long-term follow-up
MeSH terms
Female, Follow-Up Studies, Humans, Japan, Male, Middle Aged, Prognosis, Leukemia-Lymphoma, Adult T-Cell, Proportional Hazards Models, Kaplan-Meier Estimate

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Long-term study of indolent adult T-cell leukemia-lymphoma. https://app.cochat.ai/papers/10.1182/blood-2009-09-242347
The paper
Takasaki, Y., Iwanaga, M., Imaizumi, Y., Tawara, M., Joh, T., Kohno, T., Yamada, Y., Kamihira, S., Ikeda, S., Miyazaki, Y., Tomonaga, M., & Tsukasaki, K. (2010). Long-term study of indolent adult T-cell leukemia-lymphoma. Blood. https://doi.org/10.1182/blood-2009-09-242347

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.